.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Cipla
Medtronic
Daiichi Sankyo
Citi
Fuji
Merck
Farmers Insurance
QuintilesIMS

Generated: November 21, 2017

DrugPatentWatch Database Preview

HEPARIN LOCK FLUSH Drug Profile

« Back to Dashboard

What is the patent landscape for Heparin Lock Flush, and when can generic versions of Heparin Lock Flush launch?

Heparin Lock Flush is a drug marketed by Solopak, Smith And Nephew, Parke Davis, Intl Medication, Luitpold, and Hospira. and is included in seventeen NDAs.

The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for HEPARIN LOCK FLUSH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solopak
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION087903-001Apr 20, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION088581-001Oct 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Intl Medication
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION086357-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION087906-001Apr 20, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Solopak
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION088459-001Jul 26, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Solopak
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION088457-001Oct 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Luitpold
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION089064-001Oct 9, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Luitpold
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION089063-001Oct 9, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Smith And Nephew
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION087904-001Apr 20, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Solopak
HEPARIN LOCK FLUSH
heparin sodium
INJECTABLE;INJECTION087905-001Apr 20, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
Moodys
Cerilliant
Express Scripts
US Department of Justice
Federal Trade Commission
Deloitte
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot